aTyr Pharma Ord Shs
LIFE10.130USD
+0.030+0.30%
종가 03/27, 16:00（ET）시세는 15분 지연됩니다
633.72M시가총액
8.91P/E TTM
자세한 내용은 aTyr Pharma Ord Shs 회사
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
aTyr Pharma Ord Shs 정보
종목 코드 LIFE
회사 이름Ethos Technologies Inc
상장일May 07, 2015
CEOColis (Peter George)
직원 수- -
유형Ordinary Share
회계 연도 종료May 07
주소1606 Headway Circle
도시AUSTIN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호78754
전화13026365400
웹사이트https://www.ethos.com/
종목 코드 LIFE
상장일May 07, 2015
CEOColis (Peter George)
aTyr Pharma Ord Shs의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nancy E. Denyes, J.D.
Ms. Nancy E. Denyes, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Sara A. Zaknoen, M.D.
Dr. Sara A. Zaknoen, M.D.
Independent Director
Independent Director
--
--
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Fri, Feb 20
마지막 업데이트: Fri, Feb 20
주주
주주 유형
주주
주주
비율
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
기타
58.79%
주주
주주
비율
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
기타
58.79%
주주 유형
주주
비율
Venture Capital
24.49%
Individual Investor
12.09%
Investment Advisor
10.75%
Investment Advisor/Hedge Fund
0.79%
기타
51.88%
기관 주식 보유
마지막 업데이트: Fri, Jan 30
마지막 업데이트: Fri, Jan 30
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
240
61.49M
62.75%
-12.15M
2025Q4
244
60.50M
61.75%
-16.64M
2025Q3
241
62.16M
63.44%
-11.39M
2025Q2
207
66.51M
74.72%
-166.29K
2025Q1
151
62.77M
70.80%
+2.91M
2024Q4
133
55.86M
66.65%
-3.11M
2024Q3
108
48.56M
65.39%
-7.43M
2024Q2
103
48.81M
71.98%
+527.76K
2024Q1
101
42.52M
63.83%
-4.61M
2023Q4
100
41.92M
72.67%
-1.23M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Fidelity Management & Research Company LLC
14.70M
15%
+1.35M
+10.09%
Sep 30, 2025
Federated Hermes Global Investment Management Corp.
10.54M
10.76%
-4.12M
-28.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.98M
6.1%
+635.14K
+11.89%
Sep 30, 2025
The Vanguard Group, Inc.
4.96M
5.06%
-669.06K
-11.88%
Dec 31, 2025
State Street Investment Management (US)
4.20M
4.28%
+2.96M
+238.49%
Sep 30, 2025
GSA Capital Partners LLP
706.73K
0.72%
+210.44K
+42.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.18M
2.22%
+80.13K
+3.82%
Sep 30, 2025
Millennium Management LLC
1.89M
1.93%
+290.72K
+18.17%
Sep 30, 2025
UBS Financial Services, Inc.
4.34M
4.43%
+2.59M
+148.61%
Sep 30, 2025
Schimmel (Paul R Ph.D.)
1.10M
1.12%
+100.00K
+9.99%
Mar 01, 2025
더 보기
관련 ETF
마지막 업데이트: Fri, Jan 30
마지막 업데이트: Fri, Jan 30
이름
비율
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Value ETF
0%
Vanguard US Momentum Factor ETF
0%
Pacer WealthShield ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
더 보기
iShares Micro-Cap ETF
비율0.01%
ProShares Hedge Replication ETF
비율0%
Global X Russell 2000 ETF
비율0%
Invesco Dorsey Wright SmallCap Momentum ETF
비율0%
iShares Russell 2000 Value ETF
비율0%
Vanguard US Momentum Factor ETF
비율0%
Pacer WealthShield ETF
비율0%
Direxion Daily S&P Biotech Bull 3X Shares
비율0%
Avantis US Small Cap Equity ETF
비율0%
ProShares UltraPro Russell2000
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
